Promising Penny Stocks To Follow Now – May 4th

04 May 2026, 15:12 by Teresa Graham · The Cerbat Gem

Mobile-health Network Solutions, JetBlue Airways, Datavault AI, Cabaletta Bio, and Blaize are the five Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of typically small or microcap companies—under the U.S. SEC’s common threshold of $5 per share—and are often traded on OTC markets or smaller exchanges rather than major listings. They tend to be thinly traded and lightly regulated, making them highly volatile, illiquid, and subject to greater risk of price manipulation and loss, so they are considered speculative investments. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Mobile-health Network Solutions (MNDR)

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website.

Read Our Latest Research Report on MNDR

JetBlue Airways (JBLU)

JetBlue Airways Corporation provides air transportation services. The company operates a fleet of Airbus A321, Airbus A220, Airbus A321neo, Airbus A320 Restyled, Airbus A320, Airbus A321 with Mint, Airbus A321neo with Mint, Airbus A321neoLR with Mint, and Embraer E190 aircraft. It also serves 100 destinations across the United States, the Caribbean and Latin America, Canada, and Europe.

Read Our Latest Research Report on JBLU

Datavault AI (DVLT)

Datavault AI Inc., a data sciences technology company, owns and operates data management and supercomputer platforms. It offers data technology and software solutions. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc.

Read Our Latest Research Report on DVLT

Cabaletta Bio (CABA)

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is CABA-201, a fully human anti-CD19 binder for the treatment of Phase 1/2 clinical trials in dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, lupus nephritis, non-renal systemic lupus erythematosus, systemic sclerosis, and generalized myasthenia gravis.

Read Our Latest Research Report on CABA

Blaize (BZAI)

Blaize® has created a transformative new compute solution that unites silicon and software to optimize AI from the edge to the core. We’re partnering with customers to transform their products so they can deliver better experiences and better lives.